Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank64
3Y CAGR-17.9%
5Y CAGR+4.5%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-17.9%/yr
vs +44.6%/yr prior
5Y CAGR
+4.5%/yr
Recent deceleration
Acceleration
-62.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$842.13M-29.3%
2024$1.19B-8.5%
2023$1.30B-14.4%
2022$1.52B+17.4%
2021$1.29B+91.4%
2020$676.32M+102.3%
2019$334.28M-3.8%
2018$347.31M-7.7%
2017$376.24M+25.8%
2016$298.97M-